Botulinum Toxin A for the Treatment of Keloids

Episode von Medizin - Open Access LMU - Teil 19/22 von Ludwig-Maximilians-Universität München · 1. Januar 2012

Introduction: Keloids are the result of excessive scar tissue formation. Besides their poor aesthetic appearance, keloids can be associated with severe clinical symptoms such as pain, itching, and rigidity. Unfortunately, most therapeutic approaches remain clinically unsatisfactory. Recently, injections with botulinum toxin A (BTA) were proposed for the treatment of established keloids in a clinical trial. In this study, we aimed to verify the effects of intralesional BTA for the treatment of therapy-resistant keloids using objective measurements. In addition, the underlying molecular mechanisms were investigated using cultured keloid-derived fibroblasts. Materials and Methods: Four patients received BTA (doses varying from 70 to 140 Speywood units per session) injected directly into their keloids every 2 months for up to 6 months. Differences in height and volume were evaluated clinically and measured with a 3-D optical profiling system. Keloid-derived fibroblasts were treated with different concentrations of BTA, and expression of collagen (COL)1A1, COL1A2, COL3A1, TGF-beta 1, TGF-beta 2, TGF-beta 3, fibronectin-1, laminin-beta 2, and alpha-SMA was determined by real-time quantitative PCR. MTT and BrdU assays were used to analyze the effects of BTA on fibroblast proliferation and metabolism. Results: Intralesional administration of BTA did not result in regression of keloid tissue. No differences in expression of ECM markers, collagen synthesis, or TGF-beta could be observed after BTA treatment of keloid fibroblasts. In addition, cell proliferation and metabolism of keloid fibroblasts was not affected by BTA treatment. Conclusion: The suggested clinical efficiency of intralesional BTA for the therapy of existent keloids could not be confirmed in this study. Based on our data, the potential mechanisms of action of BTA on keloid-derived fibroblasts remain unclear. Copyright (C) 2012 S. Karger AG, Basel

Weitere Episoden von „Medizin - Open Access LMU - Teil 19/22“

• Antimicrobial Peptides and Skin: A Paradigm of Translational Medicine 1. Januar 2012
• Appraisal of WHO guidelines in maternal health using the AGREE II assessment tool. 1. Januar 2012
• Associations between blood glucose and carotid intima-media thickness disappear after adjustment for shared risk factors: the KORA F4 study. 1. Januar 2012
• Aszites, Pfortaderthrombose und hepatische Enzephalopathie bei Leberzirrhose: Aktuelle Therapieempfehlungen 1. Januar 2012
• Bioavailability, Antipsoriatic Efficacy and Tolerability of a New Light Cream with Mometasone Furoate 0.1% 1. Januar 2012
• Block of death-receptor apoptosis protects mouse cytomegalovirus from macrophages and is a determinant of virulence in immunodeficient hosts. 1. Januar 2012
• Body fat free mass is associated with the serum metabolite profile in a population-based study. 1. Januar 2012
• Color in context: psychological context moderates the influence of red on approach- and avoidance-motivated behavior. 1. Januar 2012
• Comparison of Intravitreal Bevacizumab Upload Followed by a Dexamethasone Implant versus Dexamethasone Implant Monotherapy for Retinal Vein Occlusion with Macular Edema 1. Januar 2012
• Cultured subventricular zone progenitor cells transduced with neurogenin-2 become mature glutamatergic neurons and integrate into the dentate gyrus. 1. Januar 2012
• DRGs in Transfusion Medicine and Hemotherapy in Germany 1. Januar 2012
• Efficacy and Patient-Reported Outcomes of a New Mometasone Cream Treating Atopic Eczema 1. Januar 2012
• Evaluating Depressive Symptoms in Schizophrenia: A Psychometric Comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale 1. Januar 2012
• Evaluation of the burden of unsuspected pulmonary tuberculosis and co-morbidity with non-communicable diseases in sputum producing adult inpatients. 1. Januar 2012
• Antidepressant drugs and the response in the placebo group: the real problem lies in our understanding of the issue 1. Januar 2012

Alle Episoden von Medizin - Open Access LMU - Teil 19/22 · Mehr Bildung-Podcasts